Clinical Trial Update: Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase I trial evaluating Pazopanib alone and in combination with Lapatinib in Japanese patients with solid tumors, including renal cell carcinoma; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Lapatinib (Lapatinib)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED